Biberach, Germany

Julia Schlichtiger

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julia Schlichtiger. Retrieved from https://idiyas.com/inventor/julia-schlichtiger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julia Schlichtiger: Innovator in Pharmaceutical Chemistry

Introduction

Julia Schlichtiger is a notable inventor based in Biberach, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Julia holds 1 patent for her invention titled "Substituted pyrazine-carboxamide derivatives." This invention relates to compounds that have potential therapeutic applications, especially in the treatment and prevention of conditions associated with the function of metabotropic glutamate receptor subtype 4 (mGluR4). The patent outlines a process for manufacturing these compounds, as well as pharmaceutical compositions that contain them.

Career Highlights

Julia Schlichtiger is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her work focuses on developing innovative solutions that address unmet medical needs.

Collaborations

Throughout her career, Julia has collaborated with esteemed colleagues, including Roland Pfau and Georg Dahmann. These partnerships have enhanced her research and contributed to the advancement of pharmaceutical sciences.

Conclusion

Julia Schlichtiger exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and collaborative efforts continue to pave the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…